← Leaderboards
Stephen Zale
Lyndra Therapeutics, Inc.
$5,700,018
Attributed
$9,127,215
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2019–21$10M$7.5M$5M$2.5M$0
'19
'20
'21
Funding mix
By agency
NIH$9,127,215 · 3
By mechanism
UG3$6,854,394 · 1
R01$1,272,821 · 1
R44$1,000,000 · 1
Top collaborators
- Richard Scranton1 shared
Most similar at Lyndra Therapeutics, Inc.
Same institution · by research overlap
- Andrew Martin Bellinger$10,090,927
- Richard Scranton$12,106,230
- Patrick Boen$8,679,033
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsAnimal ModelDosage FormsResidenceDrug Delivery SystemsAnimalsOralStomachDoseBaseFormulationFastingDrug Release KineticsEvaluationEnsureFda ApprovedCyclic GmpClinical TrialsCombined Modality TherapyClinical CandidateAdherenceDesignDrug KineticsClinical Data
Grant awards (3)
Development of Ultra Long-Acting Oral HIV Therapies$1,272,821
R01 · FY2021 · AI · contact PI
A Once-Weekly Oral Tacrolimus-Prednisone Fixed-Dose Combination Therapy for Post-Transplant Maintenance Immunosuppressive Therapy$1,000,000
R44 · FY2020 · AI · contact PI
A once-weekly oral methadone for maintenance therapy for opioid use disorder$6,854,394
UG3 · FY2019 · DA · contact PI